TransMedics(TMDX) - 2024 Q1 - Quarterly Results

Exhibit 99.1 TransMedics Reports First Quarter 2024 Financial Results Andover, Mass. – April 30, 2024 – TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended March 31, 2024. Recent Highlights ▪ Net revenue of $96.9 million in the first quarter of 2024, a 133% increase compared to the first quarter of 2023 ▪ Generated n ...